Source:http://linkedlifedata.com/resource/pubmed/id/18294153
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0005558,
umls-concept:C0022671,
umls-concept:C0038317,
umls-concept:C0085756,
umls-concept:C0181904,
umls-concept:C0443252,
umls-concept:C0596972,
umls-concept:C0728873,
umls-concept:C0733511,
umls-concept:C1274040,
umls-concept:C1521743,
umls-concept:C1704646,
umls-concept:C1709854,
umls-concept:C2825032
|
pubmed:issue |
3
|
pubmed:dateCreated |
2008-2-25
|
pubmed:abstractText |
Generally chronic steroid therapy is standard care for African American (AA) kidney recipients because of their higher incidence of rejections and lower long-term graft survival. This prospective study evaluated the long-term safety and efficacy of early steroid withdrawal (ESW) in AA recipients. A total of 206 recipients were studied; 103 AA and 103 non-AA recipients monitored by serial surveillance biopsies from 1 to 60 months posttransplantation to evaluate subclinical acute rejections (SCAR) and chronic allograft injury (CAI). Biopsy-proven clinical acute rejections (BPAR) and SCAR were treated. Primary end point was BPAR and secondary end points were 5-year SCAR, CAI and survival. Incidences of BPAR was 16% versus 14% (p = 1.0), prevalence of CAI due to hypertension was 48% versus 30% (p = 0.05) and interstitial fibrosis/tubular atrophy was 47% versus 32% (p = 0.05) and the mean serum creatinine levels were 2.1 versus 1.8 mg/dL (p = 0.05) at 5-years in AA versus non-AA recipients. The incidence of SCAR was 23% versus 11% at 1 month (p = 0.04), 12% versus 3% at 3 years (p = 0.04) and 10% versus 1% at 5 years (p = 0.04) in AA and non-AA recipients, respectively. Five-year patient survivals were 81% and 88% (p = 0.09) and graft survivals were 71% and 73%(p = 0.19) in AA and non-AA groups, respectively. After early steroid withdrawal AA kidney recipients have significantly lower renal function and higher SCAR and CAI but 5-year graft survival are comparable to non-AA recipients.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1600-6143
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
574-85
|
pubmed:dateRevised |
2010-4-29
|
pubmed:meshHeading |
pubmed-meshheading:18294153-Adult,
pubmed-meshheading:18294153-African Americans,
pubmed-meshheading:18294153-Biopsy,
pubmed-meshheading:18294153-Female,
pubmed-meshheading:18294153-Graft Rejection,
pubmed-meshheading:18294153-Graft Survival,
pubmed-meshheading:18294153-Humans,
pubmed-meshheading:18294153-Immunosuppression,
pubmed-meshheading:18294153-Incidence,
pubmed-meshheading:18294153-Kidney Transplantation,
pubmed-meshheading:18294153-Living Donors,
pubmed-meshheading:18294153-Male,
pubmed-meshheading:18294153-Prospective Studies,
pubmed-meshheading:18294153-Proteinuria,
pubmed-meshheading:18294153-Steroids,
pubmed-meshheading:18294153-Treatment Outcome
|
pubmed:year |
2008
|
pubmed:articleTitle |
Long-term outcome of early steroid withdrawal after kidney transplantation in African American recipients monitored by surveillance biopsy.
|
pubmed:affiliation |
Division of Transplantation, Department of Surgery, Drexel University College of Medicine, Philadelphia, PA, USA. akumar01@drexelmed.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|